Head-to-Head

Abbott Laboratories vs. Innoviva, Inc. Common Stock

ABT

Abbott Laboratories

$101.29 +0.22%

VS INVA

Innoviva, Inc. Common Stock

$21.34 +2.89%

Innoviva, Inc. Common Stock (INVA) comes out ahead, leading on 7 of 11 compared factors.

Size & Scale

ABTINVA
Market Cap $175.27 billion $1.50 billion
Revenue (TTM) $46.59 billion $440.00 million
Net Income (TTM) $5.42 billion $357.24 million

ABT leads on 3 of 3 size & scale factors.

Valuation

ABTINVA
P/E Ratio 32.78 5.19
Price / Book 3.39 1.21
Price / Sales 3.76 3.41

INVA leads on 3 of 3 valuation factors.

Profitability

ABTINVA
Net Margin 11.65% 81.19%
Return on Equity 10.48% 28.97%

INVA leads on 2 of 2 profitability factors.

Dividend

ABTINVA
Dividend Yield 2.49% 4.69%
Payout Ratio 81.55 24.33

INVA leads on 2 of 2 dividend factors.

Risk & Sentiment

ABTINVA
Short Interest 0.57% 19.43%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, INVA overview, INVA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.